Russia has increased the supply of radioactive isotopes to India, which will give a big boost to nuclear medicine treatment in the country.
Regional Alliance JSC, a Rusatom Healthcare company, delivered the first shipment of germanium-68/gallium-68 (Ge-68/Ga-68) generators manufactured by Cyclotron CJSC (Obninsk) under a new contract with Esente Healthcare, a local medical product distributor in India. Isotope JSC is the official supplier of the isotope package from state-run Rosatom Corporation to the international market.
Ga-68 isotope is used in nuclear medicine to diagnose a wide range of oncological diseases (cancer) using positron emission tomography (PET) scanners, allowing it to perform more than 100,000 diagnostic procedures per year globally.
According to the contract, Isotope JSC will supply the Indian side with 40 units of Ge-68/Ga-68 generators within a year. Previously, with the assistance of Isotope JSC, a registration certificate was obtained from the Central Drugs Standard Control Organisation for the commercialisation of Ge-68/Ga-68 generators from the Russian manufacturer.
Anton Shargin, deputy director general for commercial affairs, Isotope JSC said, “The supply of germanium-68/gallium-68 generators under a contract with the distributor — Esente Healthcare — opens up new opportunities for expansion of the Rosatom State Atomic Energy Corporation presence in the Indian nuclear medicine market and will also ensure the growth of trade in isotope products between our countries.”
Regional Alliance JSC, a Rusatom Healthcare company, delivered the first shipment of germanium-68/gallium-68 (Ge-68/Ga-68) generators manufactured by Cyclotron CJSC (Obninsk) under a new contract with Esente Healthcare, a local medical product distributor in India. Isotope JSC is the official supplier of the isotope package from state-run Rosatom Corporation to the international market.
Ga-68 isotope is used in nuclear medicine to diagnose a wide range of oncological diseases (cancer) using positron emission tomography (PET) scanners, allowing it to perform more than 100,000 diagnostic procedures per year globally.
According to the contract, Isotope JSC will supply the Indian side with 40 units of Ge-68/Ga-68 generators within a year. Previously, with the assistance of Isotope JSC, a registration certificate was obtained from the Central Drugs Standard Control Organisation for the commercialisation of Ge-68/Ga-68 generators from the Russian manufacturer.
Anton Shargin, deputy director general for commercial affairs, Isotope JSC said, “The supply of germanium-68/gallium-68 generators under a contract with the distributor — Esente Healthcare — opens up new opportunities for expansion of the Rosatom State Atomic Energy Corporation presence in the Indian nuclear medicine market and will also ensure the growth of trade in isotope products between our countries.”